In a meta-analysis of clinical trials, an important issue is whether the treatment benefit varies according to the underlying risk of the patients in the different trials. The usual naive analyses employed to investigate this question use either the observed risk of events in the control groups, or
Explaining heterogeneity in meta-analysis: a comparison of methods
โ Scribed by Simon G. Thompson; Stephen J. Sharp
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 160 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0277-6715
No coin nor oath required. For personal study only.
โฆ Synopsis
Exploring the possible reasons for heterogeneity between studies is an important aspect of conducting a meta-analysis. This paper compares a number of methods which can be used to investigate whether a particular covariate, with a value de"ned for each study in the meta-analysis, explains any heterogeneity. The main example is from a meta-analysis of randomized trials of serum cholesterol reduction, in which the log-odds ratio for coronary events is related to the average extent of cholesterol reduction achieved in each trial. Di!erent forms of weighted normal errors regression and random e!ects logistic regression are compared. These analyses quantify the extent to which heterogeneity is explained, as well as the e!ect of cholesterol reduction on the risk of coronary events. In a second example, the relationship between treatment e!ect estimates and their precision is examined, in order to assess the evidence for publication bias. We conclude that methods which allow for an additive component of residual heterogeneity should be used. In weighted regression, a restricted maximum likelihood estimator is appropriate, although a number of other estimators are also available. Methods which use the original form of the data explicitly, for example the binomial model for observed proportions rather than assuming normality of the log-odds ratios, are now computationally feasible. Although such methods are preferable in principle, they often give similar results in practice.
๐ SIMILAR VOLUMES
A relationship of baseline risk to treatment effect size has been suggested as a possible explanation of between-study heterogeneity in meta-analyses. To address this question, we develop regression models to examine the relationship between the logits (or other response measure) in the intervention
When combining results from separate investigations in a meta-analysis, random effects methods enable the modelling of differences between studies by incorporating a heterogeneity parameter that accounts explicitly for across-study variation. We develop a simple form for the variance of Cochran's ho